Baihui Pharmaceutical

Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. was established in 1934, and is a pharmaceutical enterprise integrating the production and sales of Chinese and Western medicine preparations and chemical raw materials. The company can produce large-volume injections, small-volume injections, oral liquid preparations, oral solid preparations, and chemical raw materials (including traditional Chinese medicine extraction) and other 14 dosage forms with over 200 varieties of drugs. All dosage forms have passed GMP certification. Sales in Guangxi local market have exceeded 100 million yuan, and the Baihui trademark has become a well-known trademark in Guangxi Province.
The company's pharmaceutical research institute is a district-level technology center with strong independent R&D capabilities. Over the years, it has adhered to the path of technological innovation, strengthened the cultivation of independent innovation capabilities, and promoted enterprise development through technological progress and product development. In recent years, it has independently developed more than ten new drugs and owns 34 registered trademarks and 6 patents.
After years of market operation, the company has formed five major marketing modules: drug raw material sales, chain brand promotion, professional medical sales, primary clinic expansion, and traditional channel sales. It has gathered a number of domestic marketing elite teams, with sales network covering the whole country, and preparation sales covering nearly 10,000 medical units and over 50,000 retail terminals across the country. Raw materials are exported to dozens of countries in Asia, Africa, Latin America, and other regions. Main products include Hair Growth Tablets, Hydrotalcite Suspension, Stanozolol Tablets, Compound Fresh Dendrobium Granules, etc. In recent years, market share has been rapidly increasing, gradually ranking among well-known domestic brand drugs. The export of Vitamin U raw material is even the highest in the world. New Baihui is on a fast track of rapid, healthy, and orderly development!

Company Development History:
In 2013, Guangxi Fengye Group wholly acquired Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., after which Baihui Pharmaceutical entered a period of rapid development.
In 2014, the first phase of the new site project for Guangxi Nanning Baihui Pharmaceutical was planned to use 150 mu of land, and a modern new factory with a total investment of 700 million yuan was under construction in Nanning Economic Development Zone, expected to be completed in 2017.
In 2018, Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. will initiate the listing procedure for its pharmaceutical segment.